You are here

Article Text

Article menu
Download PDFPDF
Correspondence
Nitric oxide in acute ischaemic stroke
  1. CARL J VAUGHAN
  1. Division of Cardiology, Department of Medicine, Weill Medical College of Cornell University, The New York Presbyterian Hospital, Starr 4, 525 E. 68th Street, New York, New York 10021, USA
  2. Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
  1. Dr Carl J Vaughan emailcvaughan{at}nyhs.med.cornell.edu
  1. NORMAN DELANTY
  1. Division of Cardiology, Department of Medicine, Weill Medical College of Cornell University, The New York Presbyterian Hospital, Starr 4, 525 E. 68th Street, New York, New York 10021, USA
  2. Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
  1. Dr Carl J Vaughan emailcvaughan{at}nyhs.med.cornell.edu

https://doi.org/10.1136/jnnp.68.1.123i

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The pivotal role of nitric oxide (NO) in cerebral ischaemia has been elegantly highlighted in the recent editorial by O'Mahony and Kendall.1 Although studies of neuroprotective agents have been largely disappointing, pharmacological manipulation of NO may represent a novel means of protecting the brain from ischaemic insult. One area not discussed in this editorial is the neuroprotective effect of 3-hydroxy-3methylglutaryl coenzyme A reductase inhibitors or “statins” in cerebral ischaemia. Preliminary studies have shown that statins modulate brain nitric …

    View Full Text